SonoScape Receives FDA 510(k) Clearance for HD-550 Endoscopy System
PR95495
SHENZHEN, China, April 15, 2022 /PRNewswire=KYODO JBN/--
On April 15th, SonoScape today announced that the U.S. Food and Drug
Administration (FDA) has approved its flagship video endoscopy system HD-550
for gastrointestinal diagnosis, setting up a major milestone on SonoScape's
Endoscopic product roadmap.
Paired with a 4-LED light source, which supports 1080P high definition, the
HD-550 endoscopy system enables multi-spectrum and multi-mode. Adding to the
high-performing white-light mode, its chromoendoscopy SFI (Spectral Focused
Imaging) and VIST (Versatile Intelligent Staining Technology) light modes
enhance vascular and mucosal color contrast. As a result, more details in the
GI tract can be revealed, which may help doctors in detection, demarcation, and
characterization of the lesions. Included in the clearance are the 550 series
videoscopes, whose maneuverability has been endorsed by top endoscopists around
the world.
The HD-550 endoscopy system has been available outside of the USA since 2019.
By 2021, HD550's top-of-the-line features and quality combined with its
versatility saw it installed in close to 40 countries around the world and has
made SonoScape the third best-selling brand in China.
"We have grown into a trusted name in the global endoscopy industry, we are now
ready to extend our offerings to the USA healthcare providers." Steven He,
Sales Director of SonoScape Endoscopy commented, "This FDA clearance opens up
opportunities in one of the world's biggest endoscopy markets, indeed is a
powerful boost of our brand recognition, and a tremendously important phase of
business development in SonoScape's 20 years' history".
About SonoScape
Founded in 2002 in Shenzhen China, SonoScape has committed itself to "Caring
for Life through Innovation" by providing ultrasound and endoscopy solutions.
With seamless support, SonoScape provides worldwide sales and service in more
than 130 countries, benefiting local hospitals and doctors with comprehensive
imaging diagnostic evidence and technical support. Investing 20% of total
revenue into R&D annually, SonoScape establishes seven R&D centers in Shenzhen,
Shanghai, Harbin, Wuhan, Tokyo, Seattle, and Silicon Valley, with more advanced
products to be introduced into the pipeline.
For more information, please visit us at https://sonoscape.com/.
SOURCE SonoScape Medical Corporation
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=419226
Caption: SonoScape HD-550 Endoscopy System
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。